FDA
This article was originally published in The Rose Sheet
Executive Summary
Former Office of Review Management Director Murray Lumpkin, MD, appointed acting deputy commissioner, making him the agency's highest ranking physician. Lumpkin will serve as acting Commissioner Schwetz' principal deputy in the near-term and may be in a position to continue in that role if HHS' selection for the commissioner post, former Center for Veterinary Medicine Director Lester Crawford, PhD, is confirmed (1"The Rose Sheet" Oct. 1, p. 7). Lumpkin, whose "position of record" will be senior associate commissioner for international activities and strategic initiatives, overseeing the Office of International Programs, is credited as one of the principle architects of FDA's faster, more predictable drug review performance during the 1990s